Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-23-006963
Filing Date
2023-04-27
Accepted
2023-04-27 08:01:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20230424xdefa14a.htm DEFA14A 19421
2 GRAPHIC tmb-20230424xdefa14a_bg001.jpg GRAPHIC 178446
3 GRAPHIC tmb-20230424xdefa14a_bg002.jpg GRAPHIC 123084
  Complete submission text file 0001558370-23-006963.txt   435924
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37625 | Film No.: 23852011
SIC: 2836 Biological Products, (No Diagnostic Substances)